Synthesis 2018; 50(01): 17-34
DOI: 10.1055/s-0036-1588569
short review
© Georg Thieme Verlag Stuttgart · New York

Studies Towards the Synthesis of (+)- and (–)-Anisomycin and Their Analogues

Sama Ajay
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Sector 10, Jankipuram Extension, Sitapur road, Lucknow-226031, U. P., India   eMail: akshaw55@yahoo.com
,
Arun K. Shaw*
Medicinal and Process Chemistry Division, CSIR-Central Drug Research Institute (CSIR-CDRI), Sector 10, Jankipuram Extension, Sitapur road, Lucknow-226031, U. P., India   eMail: akshaw55@yahoo.com
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 02. August 2017

Accepted after revision: 23. August 2017

Publikationsdatum:
04. Oktober 2017 (online)


Preview

Abstract

Anisomycin shows potent biological activity and it has attracted much attention since its isolation in 1954, with around 13 total syntheses and 20 formal syntheses, and also two reports concerning analogues of anisomycin, reported to date. The present review highlights all of these synthetic approaches (around 35) to the total or formal synthesis of anisomycin along with its isomers and analogues.

1 Introduction

2 Isolation and Therapeutic Importance

3 Total Synthesis of (+)-, (–)-, and (±)-Anisomycins and Their Analogues

4 Formal Synthesis of (+)- and (–)-Anisomycins and Their Analogues

5 Conclusion